Annals On Call Podcast
1) What You May Have Missed in 2024: Part 3
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
2) What You May Have Missed in 2024 - Part 2
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
3) High-Concentration Cannabinoids: Are They Safe?
Dr. Centor discusses currently available evidence about high-concentration cannabis products and mental health outcomes with Drs. Paula Riggs and Jonathan Samet.
4) What You May Have Missed in 2024: Part 1
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
5) Fibrillation - When Ablation is the Way to Go
Dr. Centor discusses the role of ablation in the management of patients with atrial fibrillation with Dr. Peter Zimetbaum.
6) Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
7) Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide
Dr. Centor discusses outcomes in patients with inadequately controlled type 2 diabetes when the dulaglutide dose is escalated versus switching to tirzepatide.
8) Diagnosing Primary Aldosteronism
Dr. Centor discusses the diagnosis of primary aldosteronism with Dr. Jordana Cohen.
9) Virtual Urgent Care: Artificial Intelligence Versus Physicians
Dr. Centor discusses artificial intelligence-assisted urgent care with Dr. Zehavi Kugler.
10) Pseudogout Syndrome
Dr. Centor discusses pseudogout with Dr. Robert McLean.